Yield10 Bioscience to Present at Maxim Group’s 2021 Inaugural Emerging Growth Virtual Conference
March 11 2021 - 8:30AM
Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience
company, announces that Chief Executive Officer Oliver Peoples,
PhD. will present at Maxim Group’s 2021 Inaugural Emerging
Growth Virtual Conference to be held March 17-19, 2021.
Investors can view the Yield10 corporate
presentation made by Dr. Peoples once they register for the
conference here, and an archived replay of the presentation will be
available via the conference website. Investors can also request a
1x1 meeting with management of Yield10 which will be arranged
following the conclusion of the virtual conference event.
About Yield10
Bioscience
Yield10 Bioscience, Inc. is an agricultural
bioscience company that is using its differentiated trait gene
discovery platform, the “Trait Factory”, to develop improved
Camelina varieties for the production of proprietary seed products,
and to discover high valuable genetic traits for the agriculture
and food industries. Our goals are to efficiently establish a high
value seed products business based on developing superior varieties
of Camelina for the production of feedstock oils, nutritional oils,
and PHA bioplastics, and to license our yield traits to major seed
companies for commercialization in major row crops, including corn,
soybean and canola. Yield10 is headquartered in Woburn,
MA and has an Oilseeds Center of
Excellence in Saskatoon, Canada.
For more information about the company, please
visit www.yield10bio.com, or follow the Company on Twitter,
Facebook and LinkedIn.
(YTEN G)
Contacts: Yield10 Bioscience:Lynne
H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations: Bret Shapiro, (561) 479-8566,
brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund,
eric@fischtankpr.com FischTank PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Sep 2023 to Sep 2024